Camac Partners Calls on TuSimple to Take Long Overdue Step of Monetizing Remaining Assets and Returning Capital to Shareholders NEW YORK--(BUSINESS WIRE)--Camac Partners, LLC (together with its affiliates, “Camac”), a 5.6% shareholder of TuSimple Holdings Inc. (OTCMKTS: TSPH) (“TuSimple” or the “Company”), today released a letter it recently sent to the Company's Board of Directors (the “Board”). *** May 30, 2024 TuSimple Holdings Inc. Attn: The Board of Directors Dear TuSimple Board of Directors, We are a major independent shareholder of TuSimple, owning approximately 5.6% of the Company. In our view, maintaining the C.
TuSimple Reaches Settlement Agreement With the Committee on Foreign Investment in the United States SAN DIEGO , May 29, 2024 /PRNewswire/ -- TuSimple Holdings Inc. (OTCMKTS: TSPH) ("TuSimple" or the "Company"), a global autonomous driving technology company, today announced it has reached a settlement agreement with the Committee on Foreign Investment in the United States ("CFIUS") relating to events that occurred in 2022. These events include the temporary vacancies in the security director position and on the board's government security committee (reconstituted on January 5, 2023), and whether certain covered intellectual property was transferred contrary to the national security agreement.
Nvidia Abandoned TuSimple (TSPH) Stock in Q1 Earlier this week, the deadline for regulatory disclosures sparked much intrigue regarding certain institutional investors. Among them was technology juggernaut Nvidia (NASDAQ: NVDA ).
TuSimple Appoints Two New Directors to its Board of Directors SAN DIEGO , May 6, 2024 /PRNewswire/ -- TuSimple Holdings Inc. (OTCMKTS: TSPH) ("TuSimple" or the "Company"), a global autonomous driving technology company, today announced the appointment of Albert Schultz and Jianan Hao to its Board of Directors. Schultz, an independent director, brings extensive experience from his roles at the CIA and as an entrepreneur.
Nvidia Just Invested in These 5 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch. Nvidia's biggest recent investments were in Arm Holdings and Recursion Pharmaceuticals. The big chipmaker also bought shares of Nano-X Imaging, Soundhound AI, and TuSimple Holdings.
Why Did Nvidia Invest in These 5 Artificial Intelligence (AI) Stocks? Should You Buy Them, Too? Nvidia's 13F revealed some interesting investments.
Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks. Nvidia is an AI stock that's exciting investors as much as anything else on the market right now. The company recently revealed investments in five AI stocks.
Nvidia discloses investments in smaller AI firms Nvidia (NVDA) has disclosed investments made in several emerging AI companies, sparking rallies across these stocks. Among the names benefiting include Soundhound (SOUN), Arm (ARM), and Nanox (NNOX).
Shares of Smaller AI Firms Rise After Nvidia Discloses Investments Shares of smaller artificial intelligence (AI) firms reportedly experienced a rally Thursday (Feb. 15) after Nvidia, the world's leading AI chipmaker, disclosed its stake in them as of Dec. 31. This move by Nvidia offers insights into its growth strategy and highlights its growing influence in the AI world, Reuters reported Thursday.
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW ) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company’s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion. C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday. Here are some other stocks moving in today''s mid-day session. Gainers Minim, Inc. (NASDAQ: MINM ) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim. Clearmind Medicine Inc. (NASDAQ: CMND ) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO ) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity. FibroBiologics, Inc. (NASDAQ: FBLG ) shares climbed 47.4% to $42.90.